Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodies.
Saved in:
| Title: | Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodies. |
|---|---|
| Authors: | Thran M; CureVac SE, 72076, Tübingen, Germany., Pönisch M; CureVac SE, 72076, Tübingen, Germany., Danz H; Department of Infectious Disease and Global Health, Tufts Cummings School of Veterinary Medicine, North Grafton, MA, 01536, USA., Horscroft N; CureVac SE, 72076, Tübingen, Germany., Ichtchenko K; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, 10016, USA., Tzipori S; Department of Infectious Disease and Global Health, Tufts Cummings School of Veterinary Medicine, North Grafton, MA, 01536, USA., Shoemaker CB; Department of Infectious Disease and Global Health, Tufts Cummings School of Veterinary Medicine, North Grafton, MA, 01536, USA. charles.shoemaker@tufts.edu. |
| Source: | Scientific reports [Sci Rep] 2023 Sep 05; Vol. 13 (1), pp. 14632. Date of Electronic Publication: 2023 Sep 05. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37670025 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Thran+M%22">Thran M</searchLink>; CureVac SE, 72076, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Pönisch+M%22">Pönisch M</searchLink>; CureVac SE, 72076, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Danz+H%22">Danz H</searchLink>; Department of Infectious Disease and Global Health, Tufts Cummings School of Veterinary Medicine, North Grafton, MA, 01536, USA.<br /><searchLink fieldCode="AU" term="%22Horscroft+N%22">Horscroft N</searchLink>; CureVac SE, 72076, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Ichtchenko+K%22">Ichtchenko K</searchLink>; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, 10016, USA.<br /><searchLink fieldCode="AU" term="%22Tzipori+S%22">Tzipori S</searchLink>; Department of Infectious Disease and Global Health, Tufts Cummings School of Veterinary Medicine, North Grafton, MA, 01536, USA.<br /><searchLink fieldCode="AU" term="%22Shoemaker+CB%22">Shoemaker CB</searchLink>; Department of Infectious Disease and Global Health, Tufts Cummings School of Veterinary Medicine, North Grafton, MA, 01536, USA. charles.shoemaker@tufts.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101563288%22">Scientific reports</searchLink> [Sci Rep] 2023 Sep 05; Vol. 13 (1), pp. 14632. <i>Date of Electronic Publication: </i>2023 Sep 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101563288 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-2322 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220452322%22">20452322 </searchLink><i>NLM ISO Abbreviation: </i>Sci Rep <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37670025 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41598-023-41092-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 14632 Titles: – TitleFull: Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Thran M – PersonEntity: Name: NameFull: Pönisch M – PersonEntity: Name: NameFull: Danz H – PersonEntity: Name: NameFull: Horscroft N – PersonEntity: Name: NameFull: Ichtchenko K – PersonEntity: Name: NameFull: Tzipori S – PersonEntity: Name: NameFull: Shoemaker CB IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 09 Text: 2023 Sep 05 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2045-2322 Numbering: – Type: volume Value: 13 – Type: issue Value: 1 Titles: – TitleFull: Scientific reports Type: main |
| ResultId | 1 |